Jacob Jahn

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Skye Montoya, Jessie Bourcier, Mark Noviski et al. · Science · 2024 · 148 citations · Full text

Medicine, Molecular Biology, Oncology +15

Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures

Benjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan et al. · Blood · 2023 · 37 citations · Full text

Medicine, Hematology, Oncology +10

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)

Nina Nguyen, Sana Chaudhry, Tulasigeri M. Totiger et al. · npj Precision Oncology · 2022 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Kinase Dead BTK Mutations Confer Resistance to Covalent and Noncovalent BTK Inhibitors but Are Susceptible to Clinical Stage BTK Degraders

Skye Montoya, Jessie Bourcier, Meghan C. Thompson et al. · Blood · 2022 · 17 citations

Medicine, Molecular Biology, Pharmacology +15